Mirae Asset Global ETFs Holdings’s Bristol-Myers Squibb BMY Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.4M	Sell	336,808 -74,849	-18%	-$4.3M	0.02%	509
2026 Q1	$25M	Buy	411,657 +54,063	+15%	+$3.15M	0.03%	424
2025 Q4	$19.3M	Sell	357,594 -25,155	-7%	-$1.21M	0.03%	470
2025 Q3	$17.2M	Sell	382,749 -320,879	-46%	-$15M	0.03%	484
2025 Q2	$32.6M	Buy	703,628 +435,899	+163%	+$21.4M	0.06%	289
2025 Q1	$16.3M	Sell	267,729 -17,191	-6%	-$1M	0.03%	444
2024 Q4	$16.1M	Sell	284,920 -3,042	-1%	-$170K	0.03%	429
2024 Q3	$14.9M	Sell	287,962 -20,785	-7%	-$975K	0.03%	435
2024 Q2	$12.8M	Buy	+308,747	New	+$13.8M	0.03%	464

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's BMY Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Bristol-Myers Squibb (BMY) stake by 18% in Q2 2026, selling an estimated $4.3M and leaving 336,808 shares worth $19.4M. The position accounts for 0.02% of the portfolio, ranked #509.

Mirae Asset Global ETFs Holdings first reported a position in BMY in Q2 2024 and has held it in 9 quarters since. The position peaked at $32.6M in Q2 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Mirae Asset Global ETFs Holdings held 336,808 shares of Bristol-Myers Squibb worth $19.4M as of Q2 2026.
Mirae Asset Global ETFs Holdings sold 74,849 Bristol-Myers Squibb shares in Q2 2026, an estimated $4.3M.
Bristol-Myers Squibb made up 0.02% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #509 holding.
Mirae Asset Global ETFs Holdings first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 9 quarters since.
Mirae Asset Global ETFs Holdings's Bristol-Myers Squibb position peaked at $32.6M in Q2 2025.
2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.